Traws Pharma, Inc. (TRAW) Return on equity 2017–2022
Traws Pharma, Inc. (TRAW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-177.7%FY2022 · since FY2017: -447.2% → -177.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -177.7% | -120.6 pp |
| FY2021 | -57.1% | -2.5 pp |
| FY2020 | -54.5% | +293.7 pp |
| FY2019 | -348.2% | -170.5 pp |
| FY2018 | -177.8% | +269.5 pp |
| FY2017 | -447.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice